Is tight glycemic control in type 2 diabetes really worthwhile?: NO
Wilson G et al. - Our culture of "tight control" in diabetes management too often tyrannizes patients, with little gain.
- The current literature is ambiguous regarding the benefits of tight glycemic control, with results ranging from increased mortality to modest improvement for a subset of clinically important end points.
- No trial has demonstrated reduced rates of stroke or peripheral vascular disease, nor is there empiric evidence to support self-monitoring for stable type 2 diabetes patients not taking insulin.
- Patients deserve to know the ambiguity of the evidence and to receive more support to make choices that reflect what they value.
[more...]
|
|
|
